Status:
RECRUITING
The Derivation of Human Embryonic Stem Cell Lines From PGD Embryos
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Infertility
Eligibility:
All Genders
18+ years
Brief Summary
Human embryonic stem cells (hESCs) are isolated from the early human embryo and have the capability to proliferate indefinitely in culture and to develop into nearly every cell of the human body. hESC...
Detailed Description
Embryonic stem cells are pluripotent cells that are derived from the early stage embryo (the blastocyst stage). Embryonic stem cells are the only cells that have the ability to provide an unlimited so...
Eligibility Criteria
Inclusion
- Couple has derived embryos by IVF.
- Couple has tested these embryos by PGD and does not want to utilize the embryos to build their families.
- Couple signs informed consent.
Exclusion
- Couple does not sign informed consent.
Key Trial Info
Start Date :
April 6 2004
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2030
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT00353210
Start Date
April 6 2004
End Date
December 1 2030
Last Update
March 5 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel, 91120